Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Neoplasms 2Cancer Pain 2Squamous Cell Carcinoma of Head and Neck 1Opioid-Related Disorders 1Neuralgia 1Mucositis 1Lymphoma, Follicular 1

Interventions

Radiotherapy 6Fibroblast Growth Factor 7 4Injections 3Drug Therapy 3Cisplatin 3Water 2Propolis 2Mouthwashes 2Morphine 2Methotrexate 2Melphalan 2Low-Level Light Therapy 2Interleukin 1 Receptor Antagonist Protein 2Gabapentin 2Cryotherapy 2peppermint oil 1pegaspargase 1oxycodone-acetaminophen 1nelarabine 1kang-lai-te 1glucarpidase 1fludarabine phosphate 1fish oil triglycerides 1cyclohexaneacetic acid 1calcium phosphate 1brilacidin 1anise oil 1amlexanox 1aluminum hydroxide, magnesium hydroxide, drug combination 1acetaminophen, hydrocodone drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mucositis × Buprenorphine × Clear all
NCT04752384 2025-04-20

Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients

Medical College of Wisconsin

Phase 2 Completed
20 enrolled 10 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡